Boring CL, Squires TS, Tong T. Cancer statistics, 1992. CA Cancer
J Clin. 1992;42:3-8.
Le Chevalier T, Brisgand D, Douillard J-Y, et al. Randomized study of
vinorelbine and cisplatin versus vindesine and cisplatin versus
vinorelbine alone in advanced non-small-cell lung cancer: results of a
European multicenter trial including 612 patients. J Clin Oncol.
Zhou XJ, Lacarelle B, de Souza G, et al. In vitro biotransformation
of Navelbine by animal and human hepatic subcellular fractions. Bull
ONS Clinical Practice Committee. Cancer Chemotherapy Guidelines:
Recommendations for the management of vesicant extravasation,
hypersensitivity, and anaphylaxis. Pittsburgh, Pa:
Oncology Nursing Society; 1992: 1-4.
Recommendations for the Safe Handling of Parenteral
Antineoplastic Drugs. Washington, DC: Division of Safety, National
Institutes of Health, US Department of Health and Human Services, Public
Health Service publication NIH 83-2621; 1983.
AMA Council on Scientific Affairs. Guidelines for handling parenteral
antineoplastics. JAMA. 1985;253:1590-1592.
Recommendations for the safe handling of cytotoxic drugs. Washington,
DC: US Dept of Health and Human Services, Public Health Service, National
Institutes of Health; 1992. National Institutes of Health publication
Clinical Oncological Society of Australia. Guidelines and
recommendations for safe handling of antineoplastic agents. Med J
Jones RB, Frank R, Mass T. Safe handling of chemotherapeutic agents:
a report from the Mount Sinai Medical Center. CA-A Cancer J for
American Society of Hospital Pharmacists. ASHP technical assistance
bulletin on handling cytotoxic and hazardous drugs. Am J Hosp
OSHA work-practice guidelines for personnel dealing with cytotoxic
Am J Hosp Pharm. 1986;43:1193-1204.
Trissel LA, Martinez JF. Visual, turbidimetric, and particle-content
assessment of compatibility of vinorelbine tartrate with selected drugs
during simulated Y-site injection. Am J Hosp Pharm.